The Neuromodulation Program studies and treats psychiatric disorders with the use of non-invasive neuromodulatory techniques.

Neuromodulation takes advantage of the brain’s electrical properties by inducing weak electrical currents on its cells and causing localized neurochemical changes

The MGSS is made up of independent investigators, research associates, graduate PhD and MSc level students, and research collaborators.

Marcelo Berlim is mainly interested in the study and treatment of depressive disorders with the use of state-of-the-art neuromodulation techniques.

How does tDCS compare with rTMS and with electroconvulsive therapy (ECT) in terms of its efficacy and tolerability?

What are the main advantages of tDCS?

Are there health risks associated with rTMS?

What are the most common side effects associated with rTMS?

How does rTMS compares to electroconvulsive therapy (ECT) in terms of efficacy and tolerability?

Should I stop taking my current medications before starting rTMS treatment?